Y
Yiwu Aozuo Trading Co
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A | 6 | 8.6 | 6.5 | 10.0 | 9 Jun 2025 |
| Semaglutide | A | 2 | 8.8 | 8.0 | 9.7 | 30 Dec 2025 |
| Retatrutide | C | 26 | 8.2 | 4.9 | 10.0 | 4 Aug 2025 |
| GHK-Cu | C | 9 | 7.8 | 4.9 | 9.9 | 4 Sep 2025 |
| Cagrilintide | C | 6 | 6.9 | 4.8 | 8.0 | 28 Jun 2025 |
| Tirzepatide | C | 24 | 7.6 | 4.4 | 10.0 | 9 Jun 2025 |
| Tesamorelin | D | 7 | 7.8 | 3.3 | 10.0 | 9 Sep 2025 |
| BPC-157 | E | 11 | 7.0 | 1.9 | 9.8 | 29 Jun 2025 |
| 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | A | 7 | 8.4 | 6.0 | 10.0 | 19 Jan 2026 |
| 5-amino-1MQ | X | 1 | 4.9 | 4.9 | 4.9 | 2 Apr 2025 |
| ACE-031 | A | 9 | 7.8 | 5.8 | 9.4 | 21 May 2026 |
| AHK-CU | A | 6 | 7.5 | 5.7 | 9.0 | 19 Jan 2026 |
| Anastrozole (Arimidex) Raw | A | 7 | 7.9 | 7.1 | 9.0 | 17 May 2026 |
| Andarine S4 | A | 7 | 7.8 | 4.6 | 9.9 | 21 May 2026 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | A | 4 | 7.5 | 5.7 | 8.6 | 19 Jan 2026 |
| ARA-290 | A | 5 | 8.2 | 6.3 | 10.0 | 24 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | A | 2 | 9.7 | 9.5 | 9.9 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | A | 7 | 8.7 | 6.2 | 9.8 | 23 May 2026 |
| BPC157 5mg + TB500 5mg Blend | A | 2 | 7.1 | 5.9 | 8.3 | 19 Jan 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | A | 9 | 8.1 | 5.9 | 10.0 | 25 May 2026 |
| Cartalax | A | 2 | 7.5 | 6.6 | 8.5 | 25 May 2026 |
| Cerebrolysin | A | 2 | 8.2 | 7.4 | 8.9 | 19 Jan 2026 |
| Drostanolone Propionate (Mast P) Raw | A | 9 | 7.9 | 6.3 | 9.8 | 21 May 2026 |
| EPO | A | 4 | 7.2 | 5.8 | 8.1 | 23 May 2026 |
| GW-501516 (Cardarine) | X | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 |
| Hyaluronic acid | A | 2 | 8.8 | 8.3 | 9.3 | 20 May 2026 |
| IGF-1 LR3 | A | 8 | 7.0 | 5.7 | 9.6 | 24 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | A | 8 | 8.2 | 5.5 | 10.0 | 25 May 2026 |
| L-Carnitine 500mg | A | 2 | 7.9 | 5.9 | 9.8 | 26 Jan 2026 |
| MT-1 | A | 4 | 9.1 | 8.6 | 10.0 | 24 May 2026 |
| Phenylacetic acid CAS 103-82-2 | A | 8 | 8.2 | 6.9 | 10.0 | 21 May 2026 |
| Pinealon | A | 7 | 9.0 | 6.6 | 10.0 | 24 May 2026 |
| Primobolan E Raw | A | 5 | 7.9 | 6.1 | 9.4 | 20 May 2026 |
| PTD-DBM | A | 5 | 6.9 | 5.2 | 8.1 | 24 May 2026 |
| Retatrutide 30mg Pen Kit | A | 6 | 8.5 | 7.1 | 9.6 | 25 May 2026 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | A | 4 | 6.9 | 6.1 | 8.6 | 25 May 2026 |
| S-23 Raw | X | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| SNAP-8 | A | 8 | 7.8 | 4.2 | 10.0 | 25 May 2026 |
| SS-31 | A | 5 | 8.3 | 7.9 | 9.3 | 19 Jan 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 5.8 | 5.8 | 5.8 | 8 Jul 2025 |
| Vesugen | A | 3 | 7.6 | 6.6 | 8.5 | 25 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | GHK-Cu | 7.1 | 50mg | 47.3mg | -5.4% | 99.60% | No Label / Silver Crimp / Blue Cap |
| 25 May 2026 | 5-amino-1MQ | 4.0 | 2mg | 2.3mg | +12.5% | 98.38% | Lab F |
| 25 May 2026 | Andarine S4 | 7.9 | 10mg | 9.8mg | -1.9% | 99.23% | Lab G |
| 25 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.0 | 50mg | 55.0mg | +9.9% | 95.73% | Lab F |
| 25 May 2026 | PTD-DBM | 6.2 | 5mg | 4.8mg | -4.6% | 99.38% | Lab A |
| 25 May 2026 | SNAP-8 | 8.0 | 10mg | 10.9mg | +9.4% | 99.00% | Lab A |
| 24 May 2026 | Andarine S4 | 6.2 | 25mg | 28.5mg | +14.0% | 98.34% | Lab E |
| 24 May 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 8.5 | 500g | 584.4g | +16.9% | 99.22% | Lab C |
| 24 May 2026 | Cartalax | 7.5 | 10mg | 8.6mg | -14.4% | 97.80% | Lab A |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 7.6 | 5g | 5.9g | +17.5% | 98.07% | Lab C |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.1 | 10mg | 11.8mg | +18.4% | 95.36% | Lab D |
| 24 May 2026 | MT-1 | 9.1 | 50mg | 47.3mg | -5.5% | 97.38% | Lab B |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 8.5 | 100g | 92.9g | -7.1% | 96.71% | Lab G |
| 24 May 2026 | Pinealon | 8.1 | 20mg | 19.8mg | -0.9% | 98.49% | Lab G |
| 24 May 2026 | SNAP-8 | 7.6 | 5mg | 6.1mg | +22.2% | 98.76% | Lab A |
| 24 May 2026 | ARA-290 | 9.4 | 50mg | 56.1mg | +12.3% | 99.08% | Lab B |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 10.0 | 30mg | 31.6mg | +5.4% | 95.62% | Lab G |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.2 | 5mg | 4.3mg | -14.6% | 98.35% | Lab C |
| 24 May 2026 | EPO | 6.5 | 15mg | 14.4mg | -3.8% | 98.43% | Lab A |
| 24 May 2026 | IGF-1 LR3 | 6.1 | 30mg | 28.8mg | -3.9% | 99.29% | Lab A |
| 24 May 2026 | SS-31 | 8.8 | 2mg | 2.5mg | +23.8% | 95.65% | Lab F |
| 24 May 2026 | Ipamorelin | 9.5 | 10mg | 10.1mg | +1.0% | 99.70% | Black Label / Silver Crimp / Clear Green Cap |
| 24 May 2026 | Andarine S4 | 7.5 | 100mg | 122.2mg | +22.2% | 98.90% | Lab A |
| 24 May 2026 | Andarine S4 | 7.4 | 20mg | 17.2mg | -14.2% | 95.81% | Lab E |
| 24 May 2026 | Drostanolone Propionate (Mast P) Raw | 9.3 | 5g | 5.9g | +18.7% | 97.87% | Lab B |
| 24 May 2026 | SNAP-8 | 5.1 | 5mg | 5.3mg | +5.7% | 95.55% | Lab A |
| 24 May 2026 | SNAP-8 | 7.3 | 10mg | 9.8mg | -1.8% | 95.23% | Lab G |
| 24 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 8.5 | 250mg/ml | 232.4mg/ml | -7.0% | 97.36% | Lab C |
| 23 May 2026 | Retatrutide | 6.7 | 20mg | 19.4mg | -3.0% | 99.36% | No Label / Gold Crimp / Clear Cap |
| 23 May 2026 | Retatrutide | 9.0 | 30mg | 32.1mg | +7.0% | 99.77% | White Label / Silver Crimp / Blue Cap |
| 23 May 2026 | Retatrutide | 7.4 | 15mg | 14.5mg | -3.3% | 98.44% | White Label / Silver Crimp / Orange Cap |
| 23 May 2026 | Drostanolone Propionate (Mast P) Raw | 8.0 | 1g | 1.2g | +21.0% | 98.44% | Lab G |
| 23 May 2026 | Drostanolone Propionate (Mast P) Raw | 8.2 | 5g | 5.3g | +6.4% | 95.73% | Lab F |
| 23 May 2026 | Hyaluronic acid | 9.5 | 20mg | 24.6mg | +22.9% | 95.99% | Lab A |
| 23 May 2026 | Hyaluronic acid | 8.5 | 30mg | 33.3mg | +10.8% | 96.48% | Lab F |
| 23 May 2026 | SNAP-8 | 7.7 | 30mg | 30.7mg | +2.4% | 98.93% | Lab G |
| 23 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.2 | 50mg | 59.2mg | +18.4% | 96.01% | Lab D |
| 23 May 2026 | Tirzepatide | 9.7 | 60mg | 58.2mg | -3.0% | 99.76% | No Label / Silver Crimp / Orange Cap |
| 23 May 2026 | Tirzepatide | 10.0 | 60mg | 62.9mg | +4.8% | 99.88% | No Label / Silver Crimp / Orange Cap |
| 23 May 2026 | ACE-031 | 7.9 | 10mg | 12.1mg | +20.8% | 98.87% | Lab A |
| 23 May 2026 | ACE-031 | 7.2 | 50mg | 59.2mg | +18.4% | 97.72% | Lab F |
| 23 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.1 | 50mg | 60.8mg | +21.6% | 97.80% | Lab G |
| 23 May 2026 | IGF-1 LR3 | 8.3 | 2mg | 2.0mg | +2.1% | 98.27% | Lab F |
| 23 May 2026 | MT-1 | 9.2 | 2mg | 1.9mg | -3.2% | 98.23% | Lab F |
| 23 May 2026 | Phenylacetic acid CAS 103-82-2 | 6.6 | 10g | 11.4g | +14.2% | 99.01% | Lab E |
| 21 May 2026 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 7.5 | 5g | 4.7g | -5.9% | 97.48% | Lab D |
| 21 May 2026 | ARA-290 | 9.4 | 30mg | 30.5mg | +1.7% | 99.53% | Lab D |
| 21 May 2026 | BPC157 10mg + TB500 10mg Blend | 8.4 | 50mg | 52.6mg | +5.2% | 96.73% | Lab F |
| 21 May 2026 | Drostanolone Propionate (Mast P) Raw | 9.8 | 5g | 4.5g | -9.5% | 98.38% | Lab E |
| 21 May 2026 | Pinealon | 10.0 | 10mg | 9.3mg | -7.2% | 97.65% | Lab G |
| 21 May 2026 | Pinealon | 9.7 | 30mg | 32.3mg | +7.7% | 97.03% | Lab F |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 9.3 | 10mg | 11.9mg | +18.7% | 97.79% | Lab B |
| 21 May 2026 | ARA-290 | 8.6 | 10mg | 11.7mg | +17.0% | 96.62% | Lab F |
| 21 May 2026 | Primobolan E Raw | 7.4 | 10g | 10.9g | +8.6% | 97.80% | Lab D |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 10.0 | 15mg | 15.7mg | +4.9% | 97.83% | Lab D |
| 20 May 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 8.7 | 10g | 10.8g | +8.0% | 99.57% | Lab E |
| 20 May 2026 | Vesugen | 6.2 | 10mg | 11.1mg | +10.5% | 97.02% | Lab D |
| 19 May 2026 | Andarine S4 | 8.2 | 100mg | 109.8mg | +9.8% | 99.13% | Lab C |
| 19 May 2026 | ARA-290 | 7.6 | 20mg | 17.9mg | -10.4% | 95.17% | Lab D |
| 19 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.3 | 5mg | 4.8mg | -3.7% | 99.66% | Lab A |
| 19 May 2026 | EPO | 7.1 | 10mg | 12.4mg | +23.7% | 99.02% | Lab G |
| 19 May 2026 | GW-501516 (Cardarine) | 4.1 | 25mg | 22.7mg | -9.1% | 98.98% | Lab A |
| 19 May 2026 | IGF-1 LR3 | 7.5 | 30mg | 33.7mg | +12.4% | 99.25% | Lab A |
| 19 May 2026 | L-Carnitine 500mg | 8.3 | 100mg/ml | 104.5mg/ml | +4.5% | 97.89% | Lab C |
| 19 May 2026 | Primobolan E Raw | 6.5 | 5g | 5.5g | +10.1% | 95.75% | Lab B |
| 17 May 2026 | ACE-031 | 8.8 | 2mg | 2.4mg | +20.7% | 96.94% | Lab F |
| 17 May 2026 | AHK-CU | 9.1 | 20mg | 22.4mg | +11.9% | 96.03% | Lab B |
| 17 May 2026 | ARA-290 | 5.7 | 20mg | 23.4mg | +16.8% | 98.23% | Lab E |
| 17 May 2026 | SNAP-8 | 7.8 | 20mg | 20.2mg | +1.2% | 99.03% | Lab F |
| 29 Jan 2026 | AHK-CU | 7.2 | 5mg | 6.2mg | +24.8% | 99.00% | Lab F |
| 29 Jan 2026 | Anastrozole (Arimidex) Raw | 8.2 | 500g | 596.9g | +19.4% | 99.60% | Lab F |
| 29 Jan 2026 | IGF-1 LR3 | 10.0 | 50mg | 50.9mg | +1.8% | 99.42% | Lab B |
| 29 Jan 2026 | Pinealon | 7.6 | 30mg | 26.2mg | -12.8% | 97.57% | Lab D |
| 29 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.8 | 20mg | 19.3mg | -3.6% | 99.38% | Lab G |
| 29 Jan 2026 | SNAP-8 | 7.3 | 30mg | 27.8mg | -7.4% | 98.89% | Lab B |
| 26 Jan 2026 | AHK-CU | 6.0 | 50mg | 56.2mg | +12.5% | 96.72% | Lab D |
| 19 Jan 2026 | ACE-031 | 4.4 | 2mg | 1.7mg | -14.7% | 97.83% | Lab G |
| 19 Jan 2026 | Anastrozole (Arimidex) Raw | 7.0 | 10g | 10.1g | +1.1% | 96.77% | Lab F |
| 19 Jan 2026 | Anastrozole (Arimidex) Raw | 6.7 | 1g | 1.2g | +19.0% | 97.37% | Lab C |
| 19 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.8 | 50mg | 52.7mg | +5.4% | 99.35% | Lab F |
| 9 Jan 2026 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 7.9 | 5g | 5.1g | +1.6% | 97.45% | Lab D |
| 9 Jan 2026 | ACE-031 | 8.5 | 5mg | 4.8mg | -4.1% | 95.38% | Lab A |
| 9 Jan 2026 | Andarine S4 | 9.9 | 50mg | 42.6mg | -14.7% | 96.87% | Lab G |
| 9 Jan 2026 | EPO | 7.0 | 20mg | 19.9mg | -0.3% | 96.32% | Lab F |
| 9 Jan 2026 | IGF-1 LR3 | 6.7 | 30mg | 26.4mg | -11.9% | 95.10% | Lab A |
| 9 Jan 2026 | Phenylacetic acid CAS 103-82-2 | 7.7 | 500g | 607.4g | +21.5% | 99.71% | Lab E |
| 9 Jan 2026 | Primobolan E Raw | 4.2 | 100g | 122.8g | +22.8% | 97.74% | Lab F |
| 9 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 7.8 | 10mg | 12.2mg | +21.7% | 96.04% | Lab A |
| 7 Jan 2026 | AHK-CU | 9.3 | 15mg | 12.8mg | -14.9% | 98.24% | Lab A |
| 7 Jan 2026 | Anastrozole (Arimidex) Raw | 7.4 | 100g | 112.1g | +12.1% | 98.14% | Lab B |
| 7 Jan 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 8.6 | 5g | 4.8g | -3.9% | 98.63% | Lab B |
| 7 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 10.0 | 100mg/ml | 88.5mg/ml | -11.5% | 97.87% | Lab E |
| 7 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 5.4 | 15mg | 17.0mg | +13.1% | 97.94% | Lab D |
| 7 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.5 | 50mg | 52.4mg | +4.8% | 95.19% | Lab F |
| 7 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.8 | 50mg | 47.1mg | -5.9% | 96.89% | Lab A |
| 7 Jan 2026 | Pinealon | 9.7 | 50mg | 43.8mg | -12.4% | 99.44% | Lab B |
| 7 Jan 2026 | Pinealon | 8.8 | 20mg | 21.4mg | +7.2% | 98.49% | Lab D |
| 7 Jan 2026 | SS-31 | 6.9 | 20mg | 17.5mg | -12.7% | 97.73% | Lab E |
| 6 Jan 2026 | ACE-031 | 8.1 | 15mg | 17.8mg | +19.0% | 95.85% | Lab C |
| 6 Jan 2026 | ACE-031 | 5.7 | 20mg | 20.6mg | +3.2% | 95.06% | Lab B |
| 6 Jan 2026 | AHK-CU | 8.0 | 20mg | 18.1mg | -9.3% | 98.73% | Lab G |
| 6 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 8.2 | 30mg | 30.5mg | +1.6% | 95.67% | Lab G |
| 6 Jan 2026 | IGF-1 LR3 | 7.1 | 2mg | 1.8mg | -10.2% | 97.05% | Lab E |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.6 | 15mg | 13.4mg | -10.5% | 97.62% | Lab B |
| 6 Jan 2026 | Phenylacetic acid CAS 103-82-2 | 6.3 | 500g | 555.2g | +11.0% | 97.68% | Lab D |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 7.7 | 2mg | 2.0mg | +1.7% | 96.84% | Lab D |
| 29 Dec 2025 | ACE-031 | 5.7 | 15mg | 12.8mg | -14.7% | 99.44% | Lab G |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 9.8 | 20mg | 17.9mg | -10.5% | 99.49% | Lab A |
| 29 Dec 2025 | Phenylacetic acid CAS 103-82-2 | 8.7 | 10g | 11.8g | +18.2% | 95.78% | Lab G |
| 29 Dec 2025 | PTD-DBM | 8.3 | 10mg | 8.8mg | -11.7% | 97.43% | Lab F |
| 29 Dec 2025 | PTD-DBM | 5.6 | 10mg | 9.4mg | -6.2% | 98.56% | Lab A |
| 12 Dec 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 10.0 | 100g | 101.0g | +1.0% | 98.55% | Lab G |
| 12 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.3 | 15mg | 16.4mg | +9.5% | 96.01% | Lab E |
| 12 Dec 2025 | PTD-DBM | 6.8 | 10mg | 10.1mg | +0.9% | 96.19% | Lab C |
| 12 Dec 2025 | Retatrutide 30mg Pen Kit | 8.6 | 15mg | 14.3mg | -4.6% | 96.23% | Lab B |
| 12 Dec 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 6.4 | 10mg | 10.0mg | +0.1% | 99.39% | Lab F |
| 12 Dec 2025 | S-23 Raw | 6.5 | 100g | 86.6g | -13.4% | 99.61% | Lab A |
| 5 Dec 2025 | BPC157 10mg + TB500 10mg Blend | 9.2 | 20mg | 22.1mg | +10.3% | 99.23% | Lab G |
| 5 Dec 2025 | Primobolan E Raw | 8.3 | 10g | 10.8g | +8.0% | 99.73% | Lab E |
| 5 Dec 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.3 | 15mg | 15.1mg | +0.4% | 98.74% | Lab G |
| 5 Dec 2025 | Vesugen | 7.9 | 30mg | 30.4mg | +1.2% | 99.43% | Lab A |
| 5 Dec 2025 | Vesugen | 7.4 | 10mg | 11.7mg | +16.6% | 98.30% | Lab F |
| 23 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.3 | 5mg | 5.5mg | +9.5% | 98.25% | Lab D |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.4 | 20mg | 17.1mg | -14.7% | 96.55% | Lab E |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.6 | 20mg | 18.2mg | -9.2% | 95.71% | Lab E |
| 17 Nov 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 7.1 | 100g | 87.2g | -12.8% | 96.94% | Lab D |
| 17 Nov 2025 | Cerebrolysin | 8.6 | 15mg | 13.7mg | -8.8% | 99.66% | Lab A |
| 17 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 8.2 | 5g | 6.0g | +19.1% | 96.48% | Lab B |
| 17 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.0 | 50mg | 47.1mg | -5.8% | 95.16% | Lab B |
| 17 Nov 2025 | Pinealon | 9.3 | 50mg | 44.9mg | -10.2% | 96.79% | Lab C |
| 14 Nov 2025 | ACE-031 | 7.7 | 15mg | 15.4mg | +2.7% | 95.93% | Lab G |
| 14 Nov 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 5.4 | 500g | 437.1g | -12.6% | 97.55% | Lab F |
| 14 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 8.6 | 5g | 5.2g | +4.2% | 98.52% | Lab A |
| 14 Nov 2025 | IGF-1 LR3 | 6.6 | 2mg | 2.2mg | +11.0% | 96.22% | Lab B |
| 5 Nov 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 7.0 | 100g | 101.2g | +1.2% | 99.36% | Lab F |
| 5 Nov 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 8.5 | 500g | 447.6g | -10.5% | 99.09% | Lab A |
| 5 Nov 2025 | Andarine S4 | 8.8 | 50mg | 58.8mg | +17.6% | 99.78% | Lab E |
| 5 Nov 2025 | IGF-1 LR3 | 7.3 | 5mg | 4.5mg | -10.7% | 95.17% | Lab G |
| 5 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.8 | 20mg | 22.9mg | +14.4% | 98.76% | Lab A |
| 5 Nov 2025 | SNAP-8 | 7.9 | 2mg | 2.3mg | +17.1% | 96.30% | Lab C |
| 5 Nov 2025 | SS-31 | 8.1 | 50mg | 44.6mg | -10.8% | 96.86% | Lab C |
| 5 Nov 2025 | SS-31 | 7.0 | 50mg | 61.0mg | +22.1% | 98.83% | Lab E |
| 4 Nov 2025 | AHK-CU | 7.5 | 2mg | 2.1mg | +3.2% | 98.30% | Lab F |
| 4 Nov 2025 | Anastrozole (Arimidex) Raw | 9.3 | 100g | 115.3g | +15.3% | 99.06% | Lab G |
| 4 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 7.9 | 15mg | 15.1mg | +0.9% | 95.90% | Lab E |
| 4 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 9.0 | 2mg | 1.8mg | -8.5% | 96.72% | Lab D |
| 4 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 9.3 | 100g | 111.6g | +11.6% | 97.25% | Lab A |
| 4 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 7.8 | 5g | 5.7g | +14.6% | 97.67% | Lab F |
| 4 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 7.8 | 100g | 114.4g | +14.4% | 99.72% | Lab B |
| 4 Nov 2025 | EPO | 7.6 | 20mg | 24.7mg | +23.7% | 99.11% | Lab B |
| 4 Nov 2025 | L-Carnitine 500mg | 6.4 | 200mg/ml | 196.4mg/ml | -1.8% | 95.09% | Lab D |
| 4 Nov 2025 | Primobolan E Raw | 7.9 | 10g | 10.5g | +4.8% | 96.24% | Lab G |
| 4 Nov 2025 | Retatrutide 30mg Pen Kit | 9.1 | 10mg | 9.0mg | -10.0% | 99.62% | Lab C |
| 17 Oct 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 9.1 | 10g | 8.7g | -12.9% | 95.92% | Lab C |
| 17 Oct 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.5 | 30mg | 31.1mg | +3.6% | 97.71% | Lab F |
| 17 Oct 2025 | Cartalax | 8.1 | 30mg | 29.6mg | -1.2% | 96.91% | Lab A |
| 17 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.4 | 20mg | 17.7mg | -11.6% | 96.54% | Lab F |
| 17 Oct 2025 | MT-1 | 8.4 | 50mg | 49.5mg | -1.1% | 97.86% | Lab C |
| 17 Oct 2025 | Phenylacetic acid CAS 103-82-2 | 7.8 | 1g | 1.0g | -4.0% | 95.57% | Lab B |
| 9 Oct 2025 | Phenylacetic acid CAS 103-82-2 | 9.0 | 100g | 91.4g | -8.6% | 95.78% | Lab D |
| 9 Oct 2025 | PTD-DBM | 7.7 | 15mg | 13.5mg | -10.0% | 99.76% | Lab E |
| 9 Oct 2025 | Retatrutide 30mg Pen Kit | 8.7 | 20mg | 24.1mg | +20.6% | 99.88% | Lab F |
| 9 Oct 2025 | SS-31 | 9.6 | 10mg | 9.8mg | -2.1% | 95.71% | Lab D |
| 3 Oct 2025 | Anastrozole (Arimidex) Raw | 7.5 | 500g | 495.1g | -1.0% | 99.00% | Lab E |
| 3 Oct 2025 | Anastrozole (Arimidex) Raw | 8.3 | 10g | 12.4g | +24.1% | 95.23% | Lab D |
| 3 Oct 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.7 | 10mg | 11.5mg | +14.9% | 99.03% | Lab D |
| 3 Oct 2025 | Cerebrolysin | 8.4 | 50mg | 46.6mg | -6.8% | 97.97% | Lab E |
| 3 Oct 2025 | MT-1 | 8.3 | 50mg | 43.4mg | -13.2% | 95.64% | Lab B |